Stay updated on BCD-020 Safety & Efficacy in Indolent NHL Clinical Trial

Sign up to get notified when there's something new on the BCD-020 Safety & Efficacy in Indolent NHL Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the BCD-020 Safety & Efficacy in Indolent NHL Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Difference
    0.2%
    Check dated 2025-05-07T18:54:28.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.1%
    Check dated 2025-04-30T13:39:07.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The page has removed detailed information about a clinical study comparing BCD-020 and MabThera for treating non-Hodgkin lymphoma, while adding a new version number and a reference to Follicular Non-Hodgkin's Lymphoma.
    Difference
    25%
    Check dated 2025-04-15T23:58:17.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.1%
    Check dated 2025-04-08T17:22:48.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.2 to version 2.14.3.
    Difference
    0.1%
    Check dated 2025-04-01T13:34:40.000Z thumbnail image
  7. Check
    74 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    1%
    Check dated 2025-02-24T13:11:22.000Z thumbnail image

Stay in the know with updates to BCD-020 Safety & Efficacy in Indolent NHL Clinical Trial

Enter your email address, and we'll notify you when there's something new on the BCD-020 Safety & Efficacy in Indolent NHL Clinical Trial page.